— Applied photobiology

Light therapy, compared honestly

Four bands, four different molecular targets, four different rules. Red and near-infrared talk to an enzyme. Blue talks to a brain circuit. Ultraviolet does chemistry in your skin. Timing matters most for one of them — and dose matters for all of them.

630–680 nm

Red light

Absorbed by — Cytochrome c oxidase (oxidised bands ~660–680 nm), plus skin porphyrins

Mechanism

Absorbed by the copper and heme-iron centres of Complex IV, shifting its redox state; nitric oxide is photodissociated from the catalytic centre, relieving respiratory inhibition. Downstream: proton pumping, membrane potential, ATP, a small transient ROS pulse and Nrf2 signalling.

Timing

Any time of day — red does not suppress melatonin at ordinary intensities, so evening use is the one exposure that does not fight the clock.

Dose

Typical research doses at the tissue surface: ~4–60 J/cm², 10–100 mW/cm², minutes rather than hours. More is not better — the response is biphasic.

Evidence, graded

  • 🟡Skin: wound healing, collagen density, photoaging measuresEmerging
  • 🟡Musculoskeletal pain and delayed-onset muscle sorenessEmerging
  • 🟠Retinal function in older adults (670 nm, small trials)Hypothesis
  • 🟢CCO absorbs across this band and its spectrum is redox-dependentEstablished

Cautions

  • — Dose window is real: past the peak, effects reverse.
  • — Device irradiance claims are frequently overstated; distance changes the dose quadratically.
  • — Almost all outcome trials are small, short and heterogeneous in dosing.

Educational comparison of the published literature, not medical advice or a treatment protocol. Light exposure interacts with medication photosensitivity, eye and skin conditions, and bipolar disorder — discuss changes with a clinician.